Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine
Clinical trial NCT01778413 · COMPLETED
Trial details
- NCT number
- NCT01778413
- Sponsor
- Anna Cruceta
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-03
- Primary completion
- 2014-11-14
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.